Explore
13D/13G Activist Filings
118,739 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | TRAW | Traws Pharma, Inc. | Squadron Master Fund LP | 13G/A | 8.9% | 714K |
| Feb 17, 2026 | BRCB | Black Rock Coffee Bar, Inc. | GILDER GAGNON HOWE & CO LLC | 13G/A | 5.6% | 976K |
| Feb 17, 2026 | VTGN | VISTAGEN THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | ONEW | OneWater Marine Inc. | GILDER GAGNON HOWE & CO LLC | 13G/A | 5.0% | 824K |
| Feb 17, 2026 | SXT | SENSIENT TECHNOLOGIES CORPORATION | JANUS HENDERSON GROUP PLC | 13G/A | 4.9% | 2.1M |
| Feb 17, 2026 | MTSR | METSERA, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 3.1% | 3.2M |
| Feb 17, 2026 | MREO | MEREO BIOPHARMA GROUP PLC | JANUS HENDERSON GROUP PLC | 13G/A | 0.0% | 0 |
| Feb 17, 2026 | AKRO | AKERO THERAPEUTICS, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 4.1% | 3.4M |
| Feb 17, 2026 | AVDL | AVADEL PHARMACEUTICALS PLC | JANUS HENDERSON GROUP PLC | 13G/A | 1.9% | 1.8M |
| Feb 17, 2026 | RNA | AVIDITY BIOSCIENCES, INC. | JANUS HENDERSON GROUP PLC | 13G/A | 4.6% | 6.9M |
| Feb 17, 2026 | SPRB | SPRUCE BIOSCIENCES, INC. | Squadron Master Fund LP | 13G/A | 6.5% | 70K |
| Feb 17, 2026 | EOLS | Evolus, Inc. | Timothy P. Lynch | 13G/A | 9.9% | 6.4M |
| Feb 17, 2026 | RLMD | RELMADA THERAPEUTICS, INC. | Squadron Master Fund LP | 13G/A | 9.9% | 7.4M |
| Feb 17, 2026 | DAO | Youdao, Inc. | Orbis Investment Management Limited | 13G/A | 22.2% | 6.9M |
| Feb 17, 2026 | RXO | RXO, Inc. | Orbis Investment Management Limited | 13G/A | 20.1% | 33.0M |
| Feb 17, 2026 | QXO | QXO, Inc. | ORBIS INVESTMENT MANAGEMENT LTD | 13G/A | 12.5% | 84.2M |
| Feb 17, 2026 | PRAX | Praxis Precision Medicines, Inc. | ORBIS INVESTMENT MANAGEMENT LTD | 13G | 5.0% | 1.3M |
| Feb 17, 2026 | PTLO | Portillo's Inc. | ORBIS INVESTMENT MANAGEMENT LTD | 13G/A | 9.7% | 7.0M |
| Feb 17, 2026 | N/A | Hyperliquid Strategies Inc | D1 Capital Partners L.P. | 13G | 6.3% | 8.0M |
| Feb 17, 2026 | NBIS | Nebius Group N.V. | Orbis Investment Management Limited | 13G/A | 1.5% | 3.3M |
| Feb 17, 2026 | PALI | PALISADE BIO, INC. | Squadron Master Fund LP | 13G/A | 3.0% | 4.5M |
| Feb 17, 2026 | NCMI | National CineMedia, Inc. | ORBIS INVESTMENT MANAGEMENT LTD | 13G/A | 10.1% | 9.4M |
| Feb 17, 2026 | MCS | Marcus Corp | Orbis Investment Management Limited | 13G/A | 8.0% | 1.9M |
| Feb 17, 2026 | CLH | CLEAN HARBORS INC | D1 Capital Partners L.P. | 13G | 5.2% | 2.8M |
| Feb 17, 2026 | IMAX | IMAX CORP | Orbis Investment Management Limited | 13G/A | 9.5% | 5.1M |
| Feb 17, 2026 | ICLR | ICON PLC | ORBIS INVESTMENT MANAGEMENT LTD | 13G/A | 5.5% | 4.2M |
| Feb 17, 2026 | GTM | ZoomInfo Technologies Inc. | Ahmet H. Okumus | 13G | 7.1% | 21.6M |
| Feb 17, 2026 | GXO | GXO Logistics, Inc. | Orbis Investment Management Limited | 13G/A | 11.3% | 13.0M |
| Feb 17, 2026 | N/A | GENMAB A/S | ORBIS INVESTMENT MANAGEMENT LTD | 13G/A | 6.6% | 4.2M |
| Feb 17, 2026 | FBIN | Fortune Brands Innovations, Inc. | ORBIS INVESTMENT MANAGEMENT LTD | 13G | 6.0% | 7.3M |
| Feb 17, 2026 | EDU | New Oriental Education & Technology Group Inc. | First Beijing Investment Ltd | 13G/A | 12.3% | 194.9M |
| Feb 17, 2026 | CRSP | CRISPR Therapeutics AG | ORBIS INVESTMENT MANAGEMENT LTD | 13G/A | 6.2% | 5.9M |
| Feb 17, 2026 | FLT | Corpay, Inc. | Orbis Investment Management Limited | 13G/A | 6.7% | 4.7M |
| Feb 17, 2026 | CNK | Cinemark Holdings, Inc | Orbis Investment Management Limited | 13G/A | 13.0% | 15.0M |
| Feb 17, 2026 | FIVN | Five9, Inc. | PICTET ASSET MANAGEMENT SA | 13D/A | 7.4% | 0 |
| Feb 17, 2026 | BUR | Burford Capital Ltd | ORBIS INVESTMENT MANAGEMENT LTD | 13G/A | 8.1% | 17.7M |
| Feb 17, 2026 | BRKR | Bruker Corp | ORBIS INVESTMENT MANAGEMENT LTD | 13G/A | 9.3% | 14.1M |
| Feb 17, 2026 | KRC | Kilroy Realty Corp | D1 Capital Partners L.P. | 13G/A | 8.8% | 10.4M |
| Feb 17, 2026 | TBBB | BBB FOODS INC | ORBIS INVESTMENT MANAGEMENT LTD | 13G | 5.3% | 3.3M |
| Feb 14, 2026 | VAL | Valaris Limited | Transocean Ltd. | 13D | 18.1% | 12.6M |
| Feb 14, 2026 | N/A | K2 Capital Acquisition Corp | K2 Capital Sponsor LLC | 13D | 30.2% | 6.0M |
| Feb 14, 2026 | BULL | Webull Corp | Lishui Bojiang Chuangfu 2nd Equity Investment Partnership (Limited Partnership) | 13G/A | 2.0% | 8.3M |
| Feb 14, 2026 | N/A | Grand River Commerce, Inc. | Banc Fund IX L.P. | 13G/A | 0.0% | 0 |
| Feb 14, 2026 | CWH | Camping World Holdings, Inc. | CWGS Holding, LLC | 13G/A | 34.2% | 32.6M |
| Feb 14, 2026 | HNGE | HINGE HEALTH, INC. | Daniel Antonio Perez | 13G/A | 15.7% | 10.4M |
| Feb 14, 2026 | N/A | Mountain Commerce Bancorp | Banc Fund IX L.P. | 13G/A | 0.0% | 0 |
| Feb 14, 2026 | N/A | CION Ares Diversified Credit Fund | Apollo Management Holdings GP, LLC | 13G/A | 10.6% | 4.6M |
| Feb 14, 2026 | N/A | FS Credit Opportunities Corp. | Apollo Management Holdings GP, LLC | 13G/A | 6.3% | 25K |
| Feb 14, 2026 | N/A | Carlyle Tactical Private Credit Fund | Apollo Management Holdings GP, LLC | 13G/A | 6.8% | 2.6M |
| Feb 14, 2026 | N/A | Ares Dynamic Credit Allocation Fund, Inc. | Apollo Management Holdings GP, LLC | 13G/A | 19.0% | 760K |